PhaseBio Announces Financing And Co-Development Collaboration With SFJ Pharmaceuticals For PB2452; PhaseBio To Receive Up To $120M In Development Funding, Will Retain Exclusive Worldwide Commercial Rights To PB2452

Benzinga · 01/10/2020 14:03